Regulatory Roundup: USP and Russia's Roszdravnadzor Sign MOU

Jun 02, 2010
By PharmTech Editors

The US Pharmacopeia (USP) and Russia’s Roszdravnadzor, the federation’s regulatory healthcare agency, signed a memorandum of understanding in April 2009 to work toward protecting and improving the quality of medicines. As part of the agreement, USP announced on June 1, 2010, that it has completed a series of eight drug quality courses at Moscow’s Scientific Center for Expertise of Medical Products. Approximately 100 Russian laboratory specialists attended the workshops.